Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, Madison, Wisconsin
Correspondence: Donna M. Paulnock, Ph.D., Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706-1532. E-mail: paulnock{at}facstaff.wisc.edu
African trypanosomes cause a fatal disease of man and animals that is
characterized by extensive functional, histological, and pathological
changes in the lymphoid tissues of infected hosts, including an
increase in the numbers and activation state of macrophages. Macrophage
activation during infection is the result of exposure of these cells to
parasite components and host-derived IFN-
, produced in response to
parasite antigens. The balance of these different activation signals
may determine the outcome of infection. In the experiments described
here, we assessed the ability of the variant surface glycoprotein (VSG)
of the organism Trypanosoma brucei rhodesiense (T.b.
rhodesiense) to activate macrophages directly. Our results
demonstrate that macrophages bind and are activated by the VSG
molecule. The resulting profile of activation differs from that
stimulated by IFN-
. These results suggest that the interaction of
host macrophages with VSG released during parasite infection may be a
key component of trypanosomiasis.
Key Words: host defense innate immunity trypanosomes gene expression variant surface glycoprotein
This article has been cited by other articles:
![]() |
T. R. Dagenais, K. P. Demick, J. D. Bangs, K. T. Forest, D. M. Paulnock, and J. M. Mansfield T-Cell Responses to the Trypanosome Variant Surface Glycoprotein Are Not Limited to Hypervariable Subregions Infect. Immun., January 1, 2009; 77(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lopez, K. P. Demick, J. M. Mansfield, and D. M. Paulnock Type I IFNs Play a Role in Early Resistance, but Subsequent Susceptibility, to the African Trypanosomes J. Immunol., October 1, 2008; 181(7): 4908 - 4917. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Takeuchi, V. C. Jones, M. Kobayashi, and F. Suzuki Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum Infect. Immun., August 1, 2008; 76(8): 3657 - 3663. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Stijlemans, T. N. Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology J. Immunol., September 15, 2007; 179(6): 4003 - 4014. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Leppert, J. M. Mansfield, and D. M. Paulnock The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling J. Immunol., July 1, 2007; 179(1): 548 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Harris, N. M. Cooney, J. M. Mansfield, and D. M. Paulnock Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect. Immun., August 1, 2006; 74(8): 4530 - 4537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shi, G. Wei, W. Pan, and H. Tabel Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells J. Leukoc. Biol., August 1, 2004; 76(2): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maina, J. M. Ngotho, T. Were, J. K. Thuita, D. M. Mwangangi, J. M. Kagira, J. M. Ndung'u, and J. Sternberg Proinflammatory Cytokine Expression in the Early Phase of Trypanosoma brucei rhodesiense Infection in Vervet Monkeys (Cercopithecus aethiops) Infect. Immun., May 1, 2004; 72(5): 3063 - 3065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Coller, J. M. Mansfield, and D. M. Paulnock Glycosylinositolphosphate Soluble Variant Surface Glycoprotein Inhibits IFN-{gamma}-Induced Nitric Oxide Production Via Reduction in STAT1 Phosphorylation in African Trypanosomiasis J. Immunol., August 1, 2003; 171(3): 1466 - 1472. [Abstract] [Full Text] [PDF] |
||||